aTyr Pharma, Inc. filed its Form 10-Q with the SEC on November 6, 2026, reporting financial results for the quarterly and nine-month periods ended September 30, 2026, with the company trading on NASDAQ:ATYR.
Marten Transport, Ltd. filed its Form 10-Q with the SEC on November 6, 2026, reporting financial results for the quarterly period ended September 30, 2026, and the nine months then ended.
Karman Holdings Inc. filed its Form 10-Q with the SEC on November 6, 2026, reporting financial results for the quarterly and nine-month periods ended September 30, 2026.
Citigroup Global Markets Holdings Inc. filed a Free Writing Prospectus on November 5, 2026, summarizing the terms of Contingent Income Auto-Callable Securities due November 16, 2028, based on the worst performing of the Nasdaq-100 Index, the Russell 2000 Index, and the S&P 500 Index.
PepsiCo announced on November 6, 2026, the renewal of its beverage partnership with KFC across Australia, India, UK, Spain, Germany, France, the Netherlands, and Belgium, extending a decades-long global collaboration.
Citigroup Global Markets Holdings Inc. filed a free writing prospectus on November 5, 2026, offering Market Linked Securities auto-callable with contingent downside, linked to the lowest performing of the Dow Jones Industrial Average and the S&P 500 Index, with a stated maturity of November …
Citigroup Global Markets Holdings Inc. filed a free writing prospectus on November 5, 2026, summarizing the terms of Contingent Income Auto-Callable Securities with Memory Coupon due November 16, 2029, linked to the common stock of Advanced Micro Devices, Inc.
Goldman Sachs BDC, Inc. filed a current report on Form 8-K on November 5, 2026, disclosing its financial results for the third quarter ended September 30, 2026, and announcing a fourth quarter 2026 base dividend declaration.
Tempest Therapeutics, Inc. filed a Form 8-K on November 6, 2026, disclosing that it received a Nasdaq deficiency notice on November 4, 2026, for failing to maintain the minimum $1.00 closing bid price requirement for its common stock.
PAID, Inc. filed a current report on November 5, 2026, disclosing that effective October 31, 2026, it extended a Forbearance Agreement with Embolx, Inc. through January 31, 2027, covering a note receivable with a principal balance of $5,967,100.